These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1849986)

  • 1. Intravenous carboplatin for recurrent malignant glioma: a phase II study.
    Yung WK; Mechtler L; Gleason MJ
    J Clin Oncol; 1991 May; 9(5):860-4. PubMed ID: 1849986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
    Poisson M; Péréon Y; Chiras J; Delattre JY
    J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.
    Yung WK; Prados M; Levin VA; Fetell MR; Bennett J; Mahaley MS; Salcman M; Etcubanas E
    J Clin Oncol; 1991 Nov; 9(11):1945-9. PubMed ID: 1658242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
    Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
    J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.
    Macdonald D; Cairncross G; Stewart D; Forsyth P; Sawka C; Wainman N; Eisenhauer E
    Ann Oncol; 1996 Feb; 7(2):205-7. PubMed ID: 8777179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
    Prados MD; Warnick RE; Mack EE; Chandler KL; Rabbitt J; Page M; Malec M
    Am J Clin Oncol; 1996 Dec; 19(6):609-12. PubMed ID: 8931682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.
    Warnick RE; Prados MD; Mack EE; Chandler KL; Doz F; Rabbitt JE; Malec MK
    J Neurooncol; 1994; 19(1):69-74. PubMed ID: 7815106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
    J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.
    Follézou JY; Fauchon F; Chiras J
    Neoplasma; 1989; 36(3):349-52. PubMed ID: 2544815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
    Prados MD; Schold SC; Fine HA; Jaeckle K; Hochberg F; Mechtler L; Fetell MR; Phuphanich S; Feun L; Janus TJ; Ford K; Graney W
    Neuro Oncol; 2003 Apr; 5(2):96-103. PubMed ID: 12672281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
    Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.
    Brandes AA; Ermani M; Turazzi S; Scelzi E; Berti F; Amistà P; Rotilio A; Licata C; Fiorentino MV
    J Clin Oncol; 1999 Feb; 17(2):645-50. PubMed ID: 10080610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan therapy in adults with recurrent or progressive malignant glioma.
    Friedman HS; Petros WP; Friedman AH; Schaaf LJ; Kerby T; Lawyer J; Parry M; Houghton PJ; Lovell S; Rasheed K; Cloughsey T; Stewart ES; Colvin OM; Provenzale JM; McLendon RE; Bigner DD; Cokgor I; Haglund M; Rich J; Ashley D; Malczyn J; Elfring GL; Miller LL
    J Clin Oncol; 1999 May; 17(5):1516-25. PubMed ID: 10334539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
    Clarke K; Basser RL; Underhill C; Mitchell P; Bartlett J; Cher L; Findlay M; Dalley D; Pell M; Byrne M; Geldard H; Hill JS; Maher D; Fox RM; Green MD; Kaye AH
    J Clin Oncol; 1999 Aug; 17(8):2579-84. PubMed ID: 10561325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
    Brandes AA; Basso U; Vastola F; Tosoni A; Pasetto LM; Jirillo A; Lonardi S; Paris MK; Koussis H; Monfardini S; Ermani M
    Ann Oncol; 2003 Dec; 14(12):1727-31. PubMed ID: 14630676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
    Jeremić B; Grujicić D; Matović M
    Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.
    Cloughesy TF; Filka E; Kuhn J; Nelson G; Kabbinavar F; Friedman H; Miller LL; Elfring GL
    Cancer; 2003 May; 97(9 Suppl):2381-6. PubMed ID: 12712460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response and progression in recurrent malignant glioma.
    Hess KR; Wong ET; Jaeckle KA; Kyritsis AP; Levin VA; Prados MD; Yung WK
    Neuro Oncol; 1999 Oct; 1(4):282-8. PubMed ID: 11550320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.